84bd90f5-4a1f-42a8-8eb1-5cb062a0b6ac.png
Biotechnology Market Anticipates Soaring to a Staggering USD 3,672.9 Billion by 2032 || Market.us
08 janv. 2024 07h32 HE | Market.Us
New York, Jan. 08, 2024 (GLOBE NEWSWIRE) -- According to the market.us, the global Biotechnology market witnessed a valuation of USD 1023.8 Billion in 2022. Projections indicate a significant...
MnM_logo_TM_JPG.JPG
The Global Biotechnology Industry Outlook 2024 | MarketsandMarkets.
15 déc. 2023 09h08 HE | MarketsandMarkets Research Pvt. Ltd.
Chicago, Dec. 15, 2023 (GLOBE NEWSWIRE) -- The report "The Global Biotechnology Industry Outlook 2024", despite the economic uncertainties and post-COVID slump in recent times, biotech companies...
84bd90f5-4a1f-42a8-8eb1-5cb062a0b6ac.png
Biosimulation Market to Reach a Capital Expenditure of USD 10.1 in 2032 | CAGR of 13.7%
25 avr. 2023 14h37 HE | Market.Us
New York, April 25, 2023 (GLOBE NEWSWIRE) -- As per the latest finding of Market.us, Biosimulation Market Revenue is expected to be USD 2.9 by the end of 2022. In the long term, the market is...
Basic Image
Rafarma and Haifa Technopark Enter Talks for Joint Venture
30 avr. 2021 09h31 HE | RAFARMA PHARMACEUTICALS INC
Nicosia, Cyprus, April 30, 2021 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is pleased to announce that on April 26, 2021 the company entered negotiations and formed an action plan...
Logo.jpg
Biofrontera AG: Ludwig Lutter appointed new Chief Financial Officer effective March 1, 2021
02 févr. 2021 10h35 HE | Biofrontera AG
Leverkusen, Germany, Feb. 02, 2021 (GLOBE NEWSWIRE) -- The Supervisory Board of Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical...